Gene Therapy Prolongs Survival and Restores Function in Murine and Canine Models of Myotubular MyopathyMartin K. Childers, Anna Buj‐Bello, Michael W. Lawlor et al.|Science Translational Medicine|2014Cited by 170
503. Minimally Effective Dose of Systemic AAV8-MTM1 Needed To Prolong Survival and Correct Severe Muscle Pathology in a Canine Model of X-Linked Myotubular MyopathyDavid L. Mack, Martin K. Childers, Karine Poulard et al.|Molecular Therapy|2015Cited by 0
498. Prolonged Benefit from Systemic rAAV8 in a Canine Model of Myotubular MyopathyMatthew Elverman, Martin K. Childers, David L. Mack et al.|Molecular Therapy|2016Cited by 0